Sep 2026
A Responsive Biomimetic Nanoagonist for Pyroptosis Induction and Controlled Resiquimod Release to Enhance Tumor Photoimmunotherapy.
The designed nanoagonist HBSA@CR offers a biomimetic platform for combined photo-immunotherapy, which achieves controlled R848 release while inducing tumor cell pyroptosis, reprogramming the immunosuppressive TME, and eliciting durable antitumor immunological memory.
Wen-Feng Zeng, Jun-Tao Xie, Ye-Qi Shen et al.
· Acta Biomaterialia · 0 citations